Oncternal Therapeutics: Q2 Earnings Snapshot

August 9, 2022 GMT

SAN DIEGO (AP) _ Oncternal Therapeutics, Inc. (ONCT) on Tuesday reported a loss of $11.7 million in its second quarter.

The San Diego-based company said it had a loss of 23 cents per share.

The results met Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was also for a loss of 23 cents per share.

The biopharmaceutical company posted revenue of $191,000 in the period, which missed Street forecasts. Four analysts surveyed by Zacks expected $573,000.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ONCT at https://www.zacks.com/ap/ONCT